Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
North America
Europe
Asia
Middle East
Sector Research
Financial Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
META PLATFORMS, INC.
APPLE INC.
AMAZON.COM, INC.
TESLA, INC.
NVIDIA CORPORATION
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
World Press Review
Pump & Dump
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Trend-Following Stocks
Momentum stocks
Undervalued stocks
Quality stocks
Yield stocks
ESG stocks
Investment Themes
Homepage
Sin stocks
Education
Robotics
The Golden Age of Video Games
In Vino Veritas
Boats
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
The Cannabis Industry
Robotics
Financial Data
The Golden Age of Video Games
In Vino Veritas
Cybersecurity
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
United States
Nasdaq
Novavax, Inc.
News
Analyst Reco.
NVAX
US6700024010
NOVAVAX, INC.
(NVAX)
Add to my list
Report
Delayed Nasdaq -
04:00:00 2023-01-31 pm EST
10.91
USD
+2.44%
05:47p
Factbox-What ending the U.S. COVID health emergency means for your pocket
RE
01/26
FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26
Novavax needs 6 months to produce annual COVID shots that match new variants
RE
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Funds
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Analyst Recommendations on NOVAVAX, INC.
01/09
B. Riley Lowers Novavax's Price Target to $37 From $74, Keeps Buy Rating
MT
2022
B. Riley Lowers Novavax's Price Target to $74 From $83, Keeps Buy Rating
MT
2022
B. Riley Lowers Novavax's PT to $83 From $126 to Reflect Current Realities of COVID Boo..
MT
2022
JPMorgan Downgrades Novavax to Underweight from Neutral, Adjusts Price Target to $27 fr..
MT
2022
B. Riley Securities Lowers Novavax's Price Target to $126 from $171 After Lower-than-Ex..
MT
2022
Cowen Lowers Novavax's Price Target to $110 From $150, Maintains Outperform Rating
MT
2022
B. Riley Lowers Novavax's PT to $171 from $181, Says Volatility to Shares Largely Attri..
MT
2022
Analyst recommendations: Blackstone, Relx, Vodafone, Anglo Amer..
2022
B. Riley Adjusts Price Target on Novavax to $171 From $181, Maintains Buy Rating
MT
2022
Cantor Fitzgerald Adjusts Price Target on Novavax to $168 From $146, Reiterates Overwei..
MT
2022
Cantor Fitzgerald Adjusts Price Target on Novavax to $146 From $189, Reiterates Overwei..
MT
2022
BofA Securities Initiates Coverage on Novavax With Underperform Rating
MT
2022
B. Riley Lowers Novavax's Price Target to $181 from $203, Keeps Buy Rating
MT
2022
B. Riley Lowers Novavax's Price Target to $203 from $250, Notes Relatively Lowered Pene..
MT
2022
HC Wainwright Adjusts Price Target on Novavax to $207 From $294, Reiterates Buy Rating
MT
2022
B. Riley Lowers Novavax's PT to $250 from $265 On Supply/Distribution, Notes Higher Nea..
MT
2022
B. Riley Lowers Novavax's Price Target to $265 from $315 on Reduced Near-Term Estimates..
MT
2022
Analyst recommendations: Enbridge, GSK, PepsiCo, Moody's, Novava..
2022
Cantor Fitzgerald Adjusts Price Target on Novavax to $174 From $282, Reiterates Overwei..
MT
2022
Cowen Starts Novavax at Outperform With $150 Price Target
MT
2022
B. Riley Raises Novavax's PT to $315 from $305, Says Recent Volatility Presents Buying ..
MT
2021
Analyst recommendations: Caterpillar, Cineworld, JD Sports, Micr..
2021
JPMorgan Adjusts Novavax's Price Target to $209 from $172, Keeps Neutral Rating
MT
2021
Analyst recommendations: Berkshire Hathaway, eBay, General Elect..
2021
Novavax : B. Riley Raises Novavax's PT to $305 from $286, Notes Potential to Sup..
MT
2021
Novavax : Cantor Fitzgerald Adjusts Novavax PT to $272 From $217, Maintains Over..
MT
2021
Novavax : B. Riley Lowers Novavax' Price Target to $286 from $365, Notes Weakeni..
MT
2021
Novavax : Cantor Fitzgerald Adjusts Price Target on Novavax to $217 From $338, M..
MT
2021
Novavax : HC Wainwright Adjusts Price Target on Novavax to $294 From $317, Maint..
MT
2021
Novavax : JPMorgan Cuts Novavax to Neutral From Overweight, Price Target to $161..
MT
2021
Novavax : Jefferies Adjusts Price Target on Novavax to $235 From $310, Maintains..
MT
2021
Novavax : B. Riley Lowers Novavax' PT to $365 from $397, Says AstraZeneca's AZD1..
MT
2021
Novavax : HC Wainwright & Co. Adjusts Price Target on Novavax to $317 From $207,..
MT
2021
Novavax : B. Riley Raises Novavax' Price Target to $397 from $334 on Continued S..
MT
2021
Novavax : B. Riley Adjusts Novavax' Price Target to $334 From $223, Keeps Buy Ra..
MT
2021
Novavax : JP Morgan Adjusts Price Target for Novavax to $295 From $215, Maintain..
MT
2021
Novavax : Cantor Fitzgerald Adjusts Novavax PT to $248 From $211, Maintains Over..
MT
2020
Novavax : Jefferies Starts Novavax at Buy With $200 Price Target
MT
2020
Novavax : HC Wainwright Adjusts Novavax's Price Target to $207 From $290, Keeps ..
MT
2020
Berenberg Research Sees Global Growth in 2021 After Pfizer Vaccine News; Cyclicals, Val..
MT
Analysis
Novavax cuts full-year revenue forecast
More Must read
Upcoming event on NOVAVAX, INC.
02/27/23
FY 2022 Earnings Release (Projected)
Company calendar
Upcoming sector events
02/09/23
ALNYLAM PHARMACEUTICALS, INC. : FY 2022 Earnings Release (Projected)
02/10/23
IQVIA HOLDINGS INC. : FY 2022 Earnings Release
02/15/23
SEAGEN INC. : FY 2022 Earnings Release
02/23/23
MODERNA, INC. : FY 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research
Slave